Coronavirus (COVID-19) updates for UC San Diego Health patients and visitors. Learn More.
New Patient Registration:
About Edward Ball, MD
Edward "Ted" Ball, MD, is a board-certified hematologist and medical oncologist who treats individuals with blood-related cancers such as leukemia and lymphoma. In his role as director and chief of the UC San Diego Health / Sharp HealthCare Blood and Marrow Transplantation (BMT) Program, he leads an interdisciplinary team of physicians, advanced practitioners, nurses, social workers and support staff.
Dr. Ball offers chimeric antigen receptor (CAR) T-cell therapy to adults with relapsed or refractory B-cell lymphoma, a type of non-Hodgkin lymphoma. CAR T-cell therapy harnesses the patient's own immune cells to recognize and kill cancer cells. It is just one of many types of personalized cancer therapies offered at UC San Diego Health.
A professor in the Department of Medicine, he is a highly respected cancer researcher who studies all aspects of stem cell transplantation and has patented four of his cancer treatment innovations. Dr. Ball has published over 250 journal articles and book chapters based on his basic and clinical research.
Dr. Ball has been listed as one of "America's Top Doctors" for the last 10 years and is a past recipient of the Stohlman Award from the Leukemia Society of America. He is also a past steering committee member of the prestigious BMT Clinical Trials Network.
Prior to joining UC San Diego Health, Dr. Ball was director of the blood and marrow transplant program at the University of Pittsburgh Cancer Institute for seven years. Dr. Ball completed fellowships in hematology and oncology at The Geisel School of Medicine at Dartmouth and University Hospitals Case Medical Center in Cleveland. He completed residency training at Hartford Hospital in Connecticut and earned his medical degree from Case Western Reserve University School of Medicine in Cleveland. He is board certified in hematology, medical oncology and internal medicine.
- Case Western Reserve University, School of Medicine, Cleveland, OH
- Dartmouth Geisel School of Medicine, Hanover, NH
- University Hospital, Cleveland, OH
- Hartford Hospital, Hartford, CT
- American Board of Internal Medicine
- Medical Oncology
Conditions and Treatments
- Monoclonal Antibodies
- Cancer Immunotherapy
- Bone Marrow Transplantation
- Translational Hematology/Oncology
- Blood Cancer
- Multiple Myeloma
- Chimeric Antigen Receptor (CAR) T-Cell Therapy
- Allogeneic Stem Cell Transplant
- Autologous Stem Cell Transplant
- Blood and Marrow Stem Cell Transplantation
- Blood Disorders
- Stem Cells
- Stem Cell Transplantation for Hematologic and Non-Hematologic Indications
- Acute Leukemia
- Acute Lymphoblastic Leukemia
- Acute Myeloid Leukemia
- Hodgkin's Disease
- Hematologic Malignancies
- Nautral Killer (NK) Cell-Mediated Therapy